UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein

Oncogene

Volumn 22, Issue 29, 2003, Pages 4469-4477

  Taylor, Ewan R ^a   Boner, Winifred ^a   Dornan, Edward S ^a   Corr, Eilidh M ^a   Morgan, Iain M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

E2; HPV; Protein solubility; Transcription; UV

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN; PROTEIN P53; REPLICATION FACTOR C; REPLICATION FACTOR E1; TOPBP1 PROTEIN; UNCLASSIFIED DRUG; VIRUS E2 PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA SEQUENCE; DOWN REGULATION; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; ULTRAVIOLET B RADIATION; VIRUS GENOME; VIRUS REPLICATION; WART VIRUS;

ANTINEOPLASTIC AGENTS; DNA DAMAGE; DNA-BINDING PROTEINS; DOWN-REGULATION; HALF-LIFE; HELA CELLS; HUMANS; LEUPEPTINS; ONCOGENE PROTEINS, VIRAL; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0042669801     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206746     Document Type: Article

References (47)

1. Bellanger S, Demeret C, Goyat S and Thierry F. (2001). J. Virol., 75, 7244-7251.
2. Berg M and Stenlund A. (1997). J. Virol., 71, 3853-3863.
3. Beniston RG, Morgan IM, O'Brien V and Campo MS. (2001). Carcinogenesis, 22, 1069-1076.
4. Boner W, Taylor ER, Tsirimonaki E, Yamane K, Campo MS and Morgan IM. (2002). J. Biol. Chem., 277, 22297-22303.
5. Bouvard V, Storey A, Pim D and Banks L. (1994). EMBO J., 13, 5451-5459.
6. Breiding DE, Sverdrup F, Grossel MJ, Moscufo N, Boonchai W and Androphy EJ. (1997). Mol. Cell. Biol., 17, 7208-7219.
7. Chao SF, Rocque WJ, Daniel S, Czyzyk LE, Phelps WC and Alexander KA. (1999). Biochemistry, 38, 4586-4594.
8. Day PM, Roden RB, Lowy DR and Schiller JT. (1998). J. Virol., 12, 142-150.
9. Dell G and Gaston K. (2001). Cell Mol. Life Sci., 58, 1923-1942.
10. Desaintes C, Goyat S, Garbay S, Yaniv M and Thierry F. (1999). Oncogene, 18, 4538-4545.
11. Florenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O and Fodstad O. (1994). J. Natl. Cancer Inst., 86, 1297-1302.
12. Herceg Z and Wang ZQ. (2001). Mutat. Res., 477, 97-110.
13. Hibma MH, Raj K, Ely SJ, Stanley M and Crawford L. (1995). Eur. J. Biochem., 229, 517-525.
14. Kulms D and Schwarz T. (2002). J. Dermatol., 29, 189-196.
15. Lakin ND and Jackson SP. (1999). Oncogene, 18, 7644-7655.
16. Lee D, Kim JW, Kim K, Joe CO, Schreiber V, Menissier-De Murcia J and Choe J. (2002). Oncogene, 21, 5877-5885.
17. Lee D, Lee B, Kim J, Kim DW and Choe J. (2000). J. Biol. Chem., 275, 7045-7051.
18. Lepik D, Ilves I, Kristjuhan A, Maimets T and Ustav M. (1998). J. Virol., 72, 6822-6831.
19. Li N and Karin M. (1998). Proc. Natl. Acad. Sci. USA, 95, 13012-13017.
20. Mantovani F and Banks L. (1999). Semin. Cancer Biol., 9, 387-395.
21. Massimi P, Pim D, Bertoli C, Bouvard V and Banks L. (1999). Oncogene, 18, 7748-7754.
22. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT and Lane DP. (2000). Oncogene, 19, 2312-2323.
23. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL. (2001). Oncogene, 20, 7888-7898.
24. Nghiem P, Park PK, Kim Ys YS, Desai BN and Schreiber SL. (2002). J. Biol. Chem., 277, 4428-4434.
25. Park YB, Park MJ, Kimura K, Shimizu K, Lee SH and Yokota J. (2002). Cancer Genet. Cytogenet., 133, 105-111.
26. Patel D, Huang SM, Baglia LA and McCance DJ. (1999). EMBO J., 18, 5061-5072.
27. Penrose KJ and McBride AA. (2000). J. Virol., 74, 6031-6038.
28. Perez P, Page A and Jorcano JL. (2000). Mol. Carcinogenesis, 27, 272-279.
29. Purdie KJ, Pennington J, Proby CM, Khalaf S, de Villiers EM, Leigh IM and Storey A. (1999). EMBO J., 18, 5359-5369.
30. Rank NM and Lambert PF. (1995). J. Virol., 69, 6323-6334.
31. Romanczuk H, Thierry F and Howley PM. (1990). J. Virol., 64, 2849-2859.
32. Ruhland A and de Villiers EM. (2001). Int. J. Cancer, 91, 828-834.
33. Sanders CM, Stem PL and Maitland NJ. (1995). Virology, 211, 418-433.
34. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H. (1985). Nature, 314, 111-114.
35. Spruck CH and Strohmaier HM. (2002). Cell Cycle, 1, 250-254.
36. Steger G and Corbach S. (1997). J. Virol., 71, 50-58.
37. Steger G, Ham J, Lefebvre O and Yaniv M. (1995). EMBO J., 14, 329-340.
38. Strasswimmer J, Lorson CL, Breiding DE, Chen JJ, Le T, Burghes AH and Androphy EJ. (1999). Hum. Mol. Genet., 8, 1219-1226.
39. Stubenrauch F and Pfister H. (1994). J. Virol., 68, 6959-6966.
40. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW and Ingram AJ. (2002). J. Biol. Chem., 277, 12710-12717.
41. Titolo S, Pelletier A, Sauve F, Brault K, Wardrop E, White PW, Amin A, Cordingley MG and Archambault J. (1999). J. Virol., 73, 5282-5293.
42. Vance KW, Campo MS and Morgan IM. (1999). J. Biol. Chem., 274, 27839-27844.
43. Vandel L and Kouzarides T. (1999). EMBO J., 18, 4280-4291.
44. Webster K, Parish J, Pandya M, Stern PL, Clarke AR and Gaston K. (2000). J. Biol. Chem., 275, 87-94.
45. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD and Howley PM. (2000). EMBO J., 19, 5762-5771.
46. Yamane K, Wu X and Chen J. (2002). Mol. Cell. Biol., 22, 555-566.
47. zur Hausen HJ. (2000). Natl. Cancer Inst., 92, 690-698.